In support of this, previous studies have demonstrated that TLR2, TLR4 and RAGE are significantly increased on microglia and astrocytes during ALS progression in SOD1G93A mice, and inhibition/ablation of these components have beneficial effects on the disease outcome [6–9, 16]. The gene discussed is AGER; the disease is amyotrophic lateral sclerosis.